Article Image
IPFS News Link • Food And Drug Administration / F.D.A

FDA in Hot Seat by Senators' Demands on HCQ and HHS Pulling Rank on Tests

• https://www.coreysdigs.com, By Corey Lynn

"Physicians are concerned that the FDA's actions regarding hydroxychloroquine (HCQ) may be directly costing lives by limiting outpatient access to this potentially beneficial treatment," the letter stated.

The senators wrote that the FDA's actions on HCQ have "led to misinformation and confusion across the country. Some states have restricted the ability of physicians to write and pharmacies to fill HCQ and CQ prescriptions." The senators are correct in that the FDA has done a fine job of creating confusion, as Corey's Digs has been documenting their actions on HCQ since the beginning of this "pandemic." This also comes on the heels of the historical 24-hour censoring takedown of America's Frontline Doctors, who have been fighting to get critical information out on the benefits of HCQ.

The senators point out that "the licensed physicians we have heard from… have pointed to the low mortality rates in other countries—like India, Turkey, South Korea, and Morocco—that are using HCQ widely on outpatient COVID-19 populations before the disease progresses to more lethal stages of the virus that require hospitalization."